Home Visit
Upload
Tumor Marker Panel (270 Genes), Comprehensive, FFPE
Also known as: Tumor Marker Comprehensive (270 genes) Gene Panel by NGS, FFPE Tissue**
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 4 Weeks
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Specific substances in the blood can indicate the presence of tumours. These markers are produced by tumour cells and their levels can help in diagnosing and monitoring various types of cancer. The Comprehensive Tumor Marker Panel is an advanced diagnostic tool designed to analyze formalin-fixed paraffin-embedded (FFPE) tissue samples. This panel provides a comprehensive assessment of genetic alterations associated with various types of tumors evaluating 270 genes, enabling clinicians to gain a deeper understanding of the molecular characteristics of cancer. By examining a broad range of genes, this panel offers valuable insights into the tumor's genomic profile, facilitating personalized treatment decisions and prognostic evaluations. The Comprehensive Tumor Marker Panel, specifically designed for FFPE samples, empowers clinicians with a robust tool to guide precision medicine approaches and enhance patient care in the field of oncology.
Tumor Marker Comprehensive (270 genes) Gene Panel by NGS, FFPE Tissue** Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Tumor Marker Comprehensive (270 genes) Gene Panel by NGS, FFPE Tissue** with a clear pricing structure.
The Tumor Marker Comprehensive (270 genes) Gene Panel by NGS, FFPE Tissue** Price in Hyderabad is ₹ 47,000 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The Tumour Marker Panel detects genetic alterations in 270 genes that are associated with different types of cancer.
- To screen for cancer in high-risk individuals
- To diagnose and monitor the progression of cancer
- To evaluate the effectiveness of cancer treatment
- To detect cancer recurrence
- To assess the risk of developing certain types of cancer
The Tumour Marker Panel may be recommended if you • have symptoms suggestive of a particular type of cancer, • have a family history or genetic risk factors for certain cancers, • have been diagnosed with cancer and need to monitor its progression or response to treatment, or • are at high risk for developing certain cancers based on your medical history or genetic profile.
Abnormal results from the Tumour Marker Panel may indicate the presence of cancer or other conditions.
During the test, a healthcare professional will insert a needle into your arm to draw blood. The blood sample will be sent to a laboratory for analysis.
Follow any fasting instructions provided by your doctor, if applicable. Inform your doctor about any medications or supplements you are taking.
- Biopsy to obtain a tissue sample for further analysis
- Genetic testing to identify specific gene mutations associated with certain cancers
- Histopathology examination of tissue samples for detailed analysis
Cancer Marker Panel or Oncology Panel
Cancer is a complex disease characterised by the uncontrolled growth and spread of abnormal cells in the body. It can affect various organs and tissues, leading to serious health complications.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp
